Pregnancy outcomes in psoriasis: Why do we know so little? - 07/08/11
International Psoriasis Council
Plan
Funding for this work was provided by Astellas Pharma, which had no influence on the content or construction of this paper. |
|
Disclosure: Dr Horn consults with the International Psoriasis Council. Dr Chambers receives grant funding from Amgen, Abbott, Apotex, Bristol-Myers Squibb, Barr Laboratories, Sanofi-Pasteur, Sanofi-Aventis, Sandoz, Kali Laboratories, and TEVA Pharmaceuticals. Dr Menter has served as a consultant, investigator, speaker, or advisory board member for Abbott, Amgen, Astellas, Centocor, Galderma, Genentech, Warner Chilcott, and Wyeth. Dr Kimball has served as a consultant and investigator for Amgen, Centocor, Abbott Laboratories, Neostrata, and Galderma. She is an investigator for Stiefel. She has a fellowship program funded by Centocor. |
|
Reprint requests should be directed to harvardskinstudies@partners.org. |
Vol 61 - N° 2
P. e5-e8 - août 2009 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?